drugset / Trial / NCT02568007

Effects of Cyproheptadine on Growth and Behavior in Pediatric Feeding Disorders

NCT02568007

Phase 4 Terminated 4 enrolled Medical College of Wisconsin
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to examine the effect of standard dosing of cyproheptadine for both cycled and continuous administration, as compared to no medication, on appetite stimulation and growth in the pediatric gastroenterology feeding team patient population. The secondary aim is to evaluate the effect, if any, of the suspected tachyphylaxis that is commonly associated with cyproheptadine use. The third aim will be to examine the type and duration of side effects of cyproheptadine in this population. The ultimate goal will be to create a standardized protocol for cyproheptadine therapy in children with feeding disorders and suboptimal growth.

Timeline

Start
2015-12
Primary completion
2016-08
Completion
2016-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyproheptadine Small molecule 0.25 mg/kg

Indications

No indication recorded.